Owners, management and financials
CVR: 41059044
Previous names: ApS STM nr. 6418, Dalmore Invest (Denmark) ApS, Orifarm Manufacturing Hobro ApS
DKK 57,009,000
Gross profit
Net result: DKK 3,792,000
ORIFARM GROUP A/S (100%)
CVR · view owners
Mads Fink Eriksen
Board: Hans Carl Bøgh-Sørensen (chair) and 2 members
CVR · view management
Active
Founded 1 January 2020
CVR · view overview
64 employees
CVR · 2026
Director registered: Mads Fink Eriksen
CVR · 16/04/2026
View the full event history
Orifarm Manufacturing Hobro A/S is a Danish company of the type Aktieselskab based in Hobro, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Orifarm Manufacturing Hobro ApS and Dalmore Invest (Denmark) ApS. The management consists of Mads Fink Eriksen. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 64 employees (2026). In 2025, the company reported a gross profit of DKK 57,009,000 and a net result of DKK 3,792,000 compared with DKK 2,885,000 the year before. Equity in the 2025 report amounted to DKK 45,979,000.
Source: annual report 2025, Danish Business Authority
The financial health of Orifarm Manufacturing Hobro A/S appears stable, with consistent gross profits over the past four years, peaking at 62.3 million DKK in 2023. Profitability has shown a slight fluctuation, with a notable increase to 5.0 million DKK in 2023, followed by a decrease to 3.8 million DKK in 2025. Equity has remained relatively strong, hovering around 45 to 49 million DKK, indicating a solid capital position. However, the absence of disclosed revenue raises concerns about transparency and overall market position within the pharmaceutical manufacturing industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er udvikling og fremstilling af samt handel med lægemidler og hertil beslægtede varer.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 57M | 3.8M | 118.4M | 46M | 60 | |
| 202401/01/2024 – 31/12/2024 | 58.6M | 2.9M | 107.7M | 48.8M | 67 | |
| 202301/01/2023 – 31/12/2023 | 62.3M | 5M | 125M | 45.9M | 67 | |
| 202201/01/2022 – 31/12/2022 | 60.5M | 5M | 102.3M | 49.9M | 77 |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Orifarm Manufacturing Hobro A/S is 41059044.
Orifarm Manufacturing Hobro A/S is owned by ORIFARM GROUP A/S.
The management of Orifarm Manufacturing Hobro A/S consists of Mads Fink Eriksen.
The board of Orifarm Manufacturing Hobro A/S consists of Hans Carl Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen, with Hans Carl Bøgh-Sørensen as chair.
In 2025, Orifarm Manufacturing Hobro A/S reported a gross profit of DKK 57,009,000.
Orifarm Manufacturing Hobro A/S had 64 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Orifarm Manufacturing Hobro A/S has published its annual report for 2025. Gross profit came to DKK 57,009,000, and the net result was DKK 3,792,000.
Contact info changed: new phone: 63952700, new email: [email protected], new website: www.orifarm.com (April 17, 2026).
Contact info changed: new phone: 63952700, new email: [email protected], new website: www.orifarm.com (April 16, 2026).
As of April 16, 2026, Thomas Hørslev Hedegaard has left the board of directors of Orifarm Manufacturing Hobro A/S.
As of April 16, 2026, Mads Fink Eriksen is registered as adm. dir. of Orifarm Manufacturing Hobro A/S.
As of April 16, 2026, Thomas Hørslev Hedegaard has stepped down as adm. dir. of Orifarm Manufacturing Hobro A/S.
As of October 20, 2025, Nicki Lund Kristensen has joined the board of directors of Orifarm Manufacturing Hobro A/S.
Orifarm Manufacturing Hobro A/S has published its annual report for 2024. Gross profit came to DKK 58,604,000, and the net result was DKK 2,885,000.
As of March 17, 2025, Hans Carl Bøgh-Sørensen has joined the board of directors of Orifarm Manufacturing Hobro A/S.
As of March 17, 2025, Thomas Hørslev Hedegaard has joined the board of directors of Orifarm Manufacturing Hobro A/S.
As of March 17, 2025, Erik Sandberg has left the board of directors of Orifarm Manufacturing Hobro A/S.
As of March 16, 2025, Hans Carl Bøgh-Sørensen has left the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 1, 2024, Mads Fink Eriksen has joined the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 1, 2024, Jacob Lucassen has left the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 1, 2024, Thomas Hørslev Hedegaard is registered as adm. dir. of Orifarm Manufacturing Hobro A/S.
As of October 1, 2024, Jacob Lucassen has stepped down as adm. dir. of Orifarm Manufacturing Hobro A/S.
Orifarm Manufacturing Hobro A/S has published its annual report for 2023. Gross profit came to DKK 62,339,000, and the net result was DKK 5,035,000.
Orifarm Manufacturing Hobro A/S has published its annual report for 2022. Gross profit came to DKK 60,525,000, and the net result was DKK 5,006,000.
Orifarm Manufacturing Hobro A/S has published its interim report for the period April 1, 2021 to December 31, 2021.
As of October 20, 2021, Hans Carl Bøgh-Sørensen has joined the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 20, 2021, Allan Dinesen has left the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 20, 2021, Jacob Lucassen is registered as adm. dir. of Orifarm Manufacturing Hobro A/S.
As of October 20, 2021, Allan Dinesen has stepped down as adm. dir. of Orifarm Manufacturing Hobro A/S.
As of October 15, 2021, Jacob Lucassen has joined the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 15, 2021, Erik Sandberg has joined the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 15, 2021, Allan Dinesen has joined the board of directors of Orifarm Manufacturing Hobro A/S.
As of October 15, 2021, Allan Dinesen is registered as adm. dir. of Orifarm Manufacturing Hobro A/S.
As of October 15, 2021, Jacob Lucassen has stepped down as director of Orifarm Manufacturing Hobro A/S.
As of October 15, 2021, Erik Sandberg has stepped down as director of Orifarm Manufacturing Hobro A/S.
On October 15, 2021, the company changed its name from Orifarm Manufacturing Hobro ApS to Orifarm Manufacturing Hobro A/S.
As of October 14, 2021, Allan Dinesen has stepped down as director of Orifarm Manufacturing Hobro A/S.
Orifarm Manufacturing Hobro A/S has published its interim report for the period January 1, 2020 to March 31, 2021.
As of March 31, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Orifarm Manufacturing Hobro A/S.
As of March 31, 2021, KPMG P/S has stepped down as auditor of Orifarm Manufacturing Hobro A/S.
As of March 31, 2021, Jacob Lucassen is registered as director of Orifarm Manufacturing Hobro A/S.
As of March 31, 2021, Erik Sandberg is registered as director of Orifarm Manufacturing Hobro A/S.
As of March 31, 2021, Allan Dinesen is registered as director of Orifarm Manufacturing Hobro A/S.
As of March 31, 2021, Marianne Damgaard-Sørensen has stepped down as director of Orifarm Manufacturing Hobro A/S.
As of March 31, 2021, Ghita Astrup has stepped down as director of Orifarm Manufacturing Hobro A/S.
On March 31, 2021, the company changed its name from Dalmore Invest (Denmark) ApS to Orifarm Manufacturing Hobro ApS.
As of March 31, 2021, ORIFARM GROUP A/S is registered as an owner of Orifarm Manufacturing Hobro A/S with an ownership share of 100%.
As of July 9, 2020, KPMG P/S has been appointed auditor of Orifarm Manufacturing Hobro A/S.
As of July 9, 2020, Marianne Damgaard-Sørensen is registered as director of Orifarm Manufacturing Hobro A/S.
As of July 9, 2020, Ghita Astrup is registered as director of Orifarm Manufacturing Hobro A/S.
As of July 9, 2020, Peter Andreas Stakemann has stepped down as director of Orifarm Manufacturing Hobro A/S.
On July 9, 2020, the company changed its name from ApS STM nr. 6418 to Dalmore Invest (Denmark) ApS.
As of January 1, 2020, Peter Andreas Stakemann is registered as director of Orifarm Manufacturing Hobro A/S.
Orifarm Manufacturing Hobro A/S was founded on January 1, 2020.
